Gay and Bisexual Men’s Willingness to Use a Self-Collected Anal Cancer Screening Test by Thompson, Joshua A. et al.
Gay and Bisexual Men’s Willingness to Use a Self-Collected Anal 
Cancer Screening Test
Joshua A. Thompson, MPHA, Paul L. Reiter, PhDB,C, Annie-Laurie McRee, DrPHD, Jennifer 
L. Moss, MSPHA, and Noel T. Brewer, PhDA,E
AUNC Gillings School of Global Public Health, Chapel Hill, NC, USA
BDivison of Cancer Prevention and Control, College of Medicine, The Ohio State University, 
Columbus, OH, USA
CComprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
DDivision of Health Behavior and Health Promotion, College of Public Health, The Ohio State 
University, Columbus, OH, USA
ELineberger Comprehensive Cancer Center, Chapel Hill, NC, USA
Abstract
Objective—We investigated gay and bisexual men’s willingness to self-administer an anal 
cancer screening test at home.
Methods—We conducted two national, online cross-sectional surveys of self-identified gay and 
bisexual men: Study I in 2009 with men ages 20–59 (n=306) and Study II in 2013 with men ages 
18–26 (n=428). We used multivariate logistic regression analyses to determine variables 
associated with willingness to self-administer the screening test.
Results—Most men were willing to self-administer an anal cancer screening test (78% Study I; 
67% Study II). In Study I, willingness was higher among men who trusted anal Paps to find 
treatable cancer (adjusted odds ratio [aOR]=1.47, 95% CI 1.04–2.09) and who believed that men 
who have sex with men should be screened for anal cancer between one and three years vs. other 
intervals (aOR=2.19, 95% CI 1.17–4.10). In Study II, willingness was higher among men who 
perceived greater likelihood of anal cancer (aOR=1.57, 95% CI 1.12–2.20). Their most common 
concerns were not performing the test correctly and inaccuracy of results.
Correspondence and requests for reprints should be sent to: Noel T. Brewer, PhD, Department of Health Behavior, Gillings School of 
Global Public Health, University of North Carolina, 325 Rosenau Hall, CB 7440, Chapel Hill, NC 27599, 919-966-3282 (phone); 
919-966-2921 (fax), ntb@unc.edu. 
IRB Status: This study was approved by the institutional review board of the University of North Carolina – Chapel Hill.
Declaration of Interests
NTB has received other grants from GlaxoSmithKline and Merck Sharp & Dohme Corp. and served on paid advisory boards for 
Merck Sharp & Dohme Corp. PLR has also received additional grants from Merck Sharp & Dohme Corp.
Conflict of Interest: A research grant to NTB from Merck Sharp & Dohme Corp. funded Study I. Merck Sharp & Dohme Corp. 
played no role in the study design, planning, implementation, analysis, or reporting of the findings. NTB has received other grants 
from GlaxoSmithKline and Merck Sharp & Dohme Corp. and served on paid advisory boards for Merck Sharp & Dohme Corp. PLR 
has also received additional grants from Merck Sharp & Dohme Corp. and a research grant from Cervical Cancer-Free America, via 
an unrestricted educational grant from GlaxoSmithKline.
HHS Public Access
Author manuscript
J Low Genit Tract Dis. Author manuscript; available in PMC 2016 October 01.
Published in final edited form as:













Conclusions—Many gay and bisexual men were willing to self-administer anal cancer 
screening tests at home. If routine screening is warranted, self-collected home testing could 
improve participation.
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Incidence of common cancers affecting men in the United States (prostate, lung, and 
colorectal cancer) have declined over the past decade.1 Anal cancer incidence, however, has 
increased over the past three decades, and currently 1.5 men per 100,000 are affected per 
year.1,2 This increase is attributable, at least in part, to high incidence rates among men who 
have sex with men (MSM; ~5 men per 100,000 per year), particularly those living with HIV/
AIDS (65–131 men per 100,000 per year).2,3
The majority (>70%) of cases of anal cancer are associated with human papillomavirus 
(HPV) infection, specifically with high-risk type 16 or 18.4 Risk factors for new or 
persistent anal HPV infections include anal intercourse, having multiple sexual partners, and 
smoking.5 These risk factors may explain why high-risk HPV types are common in HIV-
negative and HIV-positive MSM (12.5% and 35.4%, respectively, for type 16).3
Anal cytological screening and treatment of dysplastic lesions could represent an important 
strategy for preventing anal cancer.6 Routine cervical Papanicolaou (Pap) testing has 
resulted in a dramatic decrease in the incidence of invasive cervical cancer in women over 
the last 50 years.7 It is possible that anal cancer screening could have similar effects for 
MSM, given the similarities between cervical and anal cancers and studies showing anal 
cytology (Pap) tests have similar accuracy to cervical Pap tests.8 No studies have been 
conducted, though, to determine anal cancer screening’s effect on mortality or other patient-
centered outcomes.9 Despite this uncertainty, some clinicians are now recommending high-
risk men, including HIV-positive MSM, be screened for anal cancer because of the high 
incidence of anal cancer.10,11
Studies of anal cancer screening behavior among MSM have focused almost exclusively on 
men’s acceptance of physician-collected Pap tests.12 Self-collected anal Paps have been 
shown to have accuracy similar to clinician-collected tests.13 Studies of self-tests for HIV 
and other sexually transmitted diseases have found high rates of acceptability among MSM, 
and it is possible that allowing men to use a self-test for anal cancer would increase 
screening uptake.14,15 The purpose of the present study was to examine gay and bisexual 
men’s willingness to use a self-collected anal cancer screening test at home and to identify 
correlates of willingness to use a self-test. Findings could help inform future programs for 
promoting anal cancer screening among this higher-risk population.
Methods
We report data from two separate cross-sectional studies of gay and bisexual men. The 
studies are described in detail elsewhere and briefly here.16,17
Thompson et al. Page 2














Sample and procedures—The sample for Study I came from an existing, national panel 
of U.S. households maintained by Knowledge Networks (Palo Alto, CA) Panel members 
were recruited using list-assisted random-digit dialing. Panel members received free Internet 
access or small cash payments in exchange for completing surveys. Study I was limited to 
men aged 18–59 and oversampled for self-identified gay and bisexual men. Of the 874 
eligible panel members invited to participate, 609 (70%) consented to and completed the 
survey in January 2009. Of those who completed the survey, 306 men self-identified as gay 
(n=236) or bisexual (n=70) and were included in the current analysis. The Institutional 
Review Board at the University of North Carolina approved this study.
Measures—The Study I survey is available online at www.unc.edu/~ntbrewer/hpv.htm. 
We developed the survey items based on our previous work on HPV-related diseases.18,19
Our primary outcome was willingness to self-administer an anal cancer screening test at 
home. Introductory text to the section on anal cancer screening read, “Doctors can use an 
anal Pap test to identify anal cancer. An anal Pap test is when a doctor collects cells from 
the anus using a swab (like an extra-long Q-tip) and examines them for changes. An anal 
Pap test is not the same as a test for anal gonorrhea, a colonoscopy, or a digital rectal 
exam.” The survey assessed willingness to get a physician-collected anal Pap test under two 
conditions: (1) if it were free and (2) if it cost $150 out of pocket. Then the survey assessed 
willingness to self-administer an anal cancer screening test: “How willing would you be to 
use an anal swab on yourself to screen for anal cancer? You would do this test at home by 
yourself instead of going to a doctor’s office.” Response options for willingness items were 
definitely wouldn’t, probably wouldn’t, not sure, probably would, and definitely would. We 
combined responses into two categories: willing (probably or definitely would) and not 
willing (all other responses).
The survey assessed participants’ awareness of HPV prior to the study and knowledge of 
HPV using five factual items. We coded three to five correct responses as high HPV 
knowledge and the rest as low HPV knowledge, based on the median number of correct 
responses for the entire sample. The survey also measured respondents’ perceived 
knowledge of several HPV-related diseases (genital warts, oral cancer, and anal cancer), as 
well their worry about the disease, perceived likelihood of developing it, and belief that 
having the disease would change their lives. Because pilot testing showed men had low 
familiarity with HPV-related disease, we included brief informative statements about each 
disease prior to asking questions about them.
We measured several demographic and health-related characteristics as potential covariates. 
We defined “urban” as living in a metropolitan statistical area based on zip code. The survey 
also asked about history of sexually transmitted infections, genital warts, lifetime number of 
sexual partners, number of partners in the past year, and whether participants had disclosed 
sexual behavior with men to their physician.
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Sample and procedures—The Study II sample was drawn from the Harris Interactive 
LGBT Panel, a subset of the Harris Poll Online Panel (Rochester, NY). The Harris Poll 
Online Panel is a voluntary research panel that includes members throughout the entire 
country; U.S. participants are similar to the general population for several demographic 
characteristics.20 Panel members who complete surveys receive points that can be 
exchanged for rewards. Inclusion criteria for Study II included being age 18–26 (because the 
primary focus of the study was on HPV vaccination among young adults), living in the US, 
and self-identifying as lesbian, gay, bisexual or transgender (LGBT). Of 2,014 eligible panel 
members, 1005 (50%) consented to and completed an online survey in October or 
November 2013. Of those who completed the survey, the 428 men who self-identified as 
gay (n=309) or bisexual (n =119) were included in the current analysis. The Institutional 
Review Board at The Ohio State University approved Study II.
Measures—We based the Study II survey on the survey used for Study I, as well as 
subsequent surveys on HPV vaccination.21,22 Our primary outcome was willingness to self-
administer an anal cancer screening test at home. The survey item read, “There is also a 
home test that may help screen for anal cancer. This test would involve using a swab (like a 
Q-tip) to get an anal specimen. You would do this test at home by yourself instead of going 
to a doctor’s office. How willing would you be to use an anal swab on yourself to screen for 
anal cancer?” As with Study I, the five response options were combined into willing to self-
test (probably or definitely willing) and not willing (note sure, probably or definitely not 
willing). An additional item asked participants to select potential concerns they had about 
using a home test for anal cancer from a list of predefined response options.
The survey assessed participants’ awareness of HPV prior to the study and knowledge of 
HPV using five factual items. We coded four or five correct responses as high HPV 
knowledge and less than four correct responses as low HPV knowledge, based on the 
median number correct for the entire sample. The survey also measured respondents’ worry 
about and perceived seriousness of HPV-related disease, as well as their perceived 
likelihood of developing specific diseases (genital warts, oral cancer, and anal cancer).
We measured several demographic and health-related characteristics as potential covariates. 
We defined “urban” as self-report of living in an urban or suburban area. The survey also 
asked about history of sexually transmitted infections, genital warts, lifetime number of 
sexual partners, number of partners in the past year, and whether participants had disclosed 
their sexual orientation to their physician.
Analyses
We analyzed data from the two studies separately, given their different samples. We used 
logistic regression to identify bivariate correlates of willingness to self-administer an anal 
cancer screening test. We entered statistically significant (p<0.05) bivariate correlates into 
multivariate logistic regression models for each study.
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We used McNemar’s test to compare Study I participants’ willingness to self-administer an 
anal cancer screening test to their willingness to get a physician collected anal cancer 
screening test that cost $150 or that was free. We used Pearson’s chi-squared test to compare 
the two study samples’ willingness to self-administer the test.
We analyzed data with Stata release 13 (StataCorp LP, 2013, College Station, TX, USA). 
All statistical tests were 2-tailed, using a critical α=0.05. Missing values were replaced using 
mean substitution.
The reporting of this paper conforms to the STROBE statement, and a completed STROBE 
checklist is available online (Supplementary Digital Content: Table 1).23
Role of the Funding Source
Study I was supported by a research grant from the Investigator-Initiated Studies Program of 
Merck Sharp & Dohme Corp. Merck Sharp & Dohme Corp. played no role in the study 
design, planning, implementation, analysis, or reporting of the findings. Additional support 
for these studies was provided by the American Cancer Society and the National Cancer 
Institute at the National Institutes of Health.
Results
Participant Characteristics
Most men in Study I identified as gay (77%) and were HIV-negative (83%) (Table 1). Their 
median age was 47 years (range 20–59), and 96% were older than 26. Most were non-
Hispanic White (81%), had a college degree (56%), were insured (86%), or lived in an urban 
area (93%). Nearly half were married or living with a partner (48%) and most had at least 
five lifetime sexual partners (89%). Only 23% had ever heard of an anal Pap before the 
survey, and 14% reported having an anal Pap in the past.
A similar proportion of men in Study II identified as gay (72%). Almost all men in Study II 
were HIV-negative (96%). Men in Study II were younger than in Study I (23 years, range 
18–26). Fewer men in Study II identified as non-Hispanic White (64%), had a college 
degree (47%), were insured (80%), or lived in an urban area (84%). Fewer were married or 
partnered (53%), and only 53% had five or more lifetime sexual partners.
Willingness to Self-Administer an Anal Cancer Screening Test
Most men in Study I (78%, 95% confidence interval [CI] 73%–82%) were willing to self-
administer an anal cancer screening test at home (Figure 1). Men were somewhat less 
willing to self-administer the test than to get a free physician-collected test (78% vs. 83%; 
χ2=4.41; p=0.04). They were much more willing to self-administer the test than to get a 
physician-collected test that cost $150 (78% vs. 31%; χ2=129.60, p<0.001).
Two-thirds of Study II men (67%, 95% CI 62%–71%) were willing to self-administer an 
anal cancer screening test at home, a lower percentage than among Study I participants 
(p<0.001). The most common concerns about self-administrating the test that participants 
cited were “I might not do the test right” (61%) and “the test might not be accurate” (59%) 
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(Figure 2). About 29% of the men said they would rather go to a doctor to get screened for 
anal cancer, 22% were concerned the test would hurt, and 17% thought it would be 
embarrassing.
Correlates of Willingness
In Study I, men’s willingness to self-administer an anal cancer test was higher if they 
believed MSM should be screened between one and three years (87%) rather than screening 
at other intervals (adjusted odds ratio [aOR]=2.19, 95% CI 1.17–4.10) in multivariate 
analysis (Table 2). Willingness was also higher among men who agreed more with the 
statement: “If I got regular anal pap tests, I would trust them to find anal cancer when it is 
still treatable.” (aOR=1.47, 95% CI 1.04–2.09). Additional correlates of willingness in 
bivariate analysis were higher worry about anal cancer, higher knowledge about HPV, belief 
that HIV affects a man’s chances of getting anal cancer, being HIV-positive, and being non-
Hispanic white when compared to “other” race/ethnicity (all p<0.05).
In Study II, willingness to self-administer an anal cancer screening test was higher among 
men who had higher perceived likelihood of developing anal cancer (aOR=1.57, 95% CI 
1.12–2.20) in multivariate analysis (Table 3). In bivariate analyses, correlates of willingness 
to use a self-test were higher worry about diseases caused by HPV, higher knowledge of 
HPV, having five or more lifetime sexual partners, having a college degree, and being older 
(all p<0.05).
Discussion
In the two national samples, most gay and bisexual were willing to self-administer an anal 
cancer screening test at home. The proportion of men willing to use a self-collected test was 
similar to or higher than those previously reported for physician-collected Pap tests.16,24 The 
possibility that men may prefer a self-collected home test is supported by our findings that 
Study I men were more willing to use the self-collected test than to get a physician-collected 
Pap that cost $150 and that fewer than a third of Study II participants indicated they would 
rather go to a doctor to get screened for anal cancer as a concern about self-testing. This is 
consistent with the literature on cervical cancer screening, which has shown that allowing 
women to self-collect HPV samples improves participation in screening programs.25 Men in 
Study I were slightly less willing to use a self-collected test than to undergo a physician-
collected Pap if offered at no cost. Offering subsidized physician-based testing and 
promoting home-testing may therefore both be reasonable options to improve screening in 
the future.
We found much greater willingness to use a self-collected anal cancer screening test than a 
previous study of acceptability among MSM; Gilbert et al. reported only 35% of men were 
willing to use a self-collected test, but their sample was limited to men attending MSM-
frequented venues and the test was collected in venue bathrooms.26 The increased privacy, 
comfort, and safety of collecting the test at home may be important components of men’s 
willingness to self-administer an anal cancer screening test.27
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We identified three potentially modifiable correlates of willingness to use self-collected 
testing in multivariate analyses. Men in Study II who perceived they had a higher likelihood 
of anal cancer were more willing to self-administer an anal cancer screening test. Reed et al. 
previously identified this association in their analysis of willingness to get a physician-
collected anal Pap test.16 Multiple health behavior studies have established that risk 
perceptions, including perceived likelihood, are important predictors of cancer screening 
participation and other health protective actions.28 This study extends that link to the use of 
self-administered cancer screening tests.
Men’s willingness to use a self-collected test in Study I was associated with their trust in 
anal Paps to find cancer when it is still treatable. Belief in the efficacy or benefits of 
screening is another construct that has been correlated with participation in cancer screening 
programs.29 However, Reed et al. did not find a statistically significant association between 
perceived test efficacy and willingness to get a physician-collected Pap.17 Similarly, 
D’Souza et al. found that belief in the utility of anal Pap tests was associated with 
acceptance of a free test among MSM in bivariate analyses, but the association was not 
significant in their multivariate model.24 It is possible that test effectiveness is more 
important to men when considering a home-based test, as a test performed by a physician 
may be assumed to have some minimal level of effectiveness. This idea is supported by 
qualitative work showing some people worry that home-based STI tests are less accurate and 
our own findings that the majority of men in Study II had concerns about the self-collected 
test’s accuracy and their ability to perform it correctly.30
The association between believing that MSM should get an anal Pap test to screen for anal 
cancer and men’s willingness to use a self-collected test may simply show that men who 
thought MSM need to be screened were themselves more willing to be screened. Perceived 
norms about engaging in health-promoting behavior have been linked to adherence to 
colorectal cancer screening recommendations.31 Our study shows that this relationship could 
also be true for anal cancer screening.
The strengths of this study were its use of two large, national samples with high 
participation rates. To our knowledge, this was the first study to explore gay and bisexual 
men’s willingness to self-administer an anal cancer screening test using a national sample.
Limitations include the cross-sectional designs and reliance on self-report for the measures, 
including HIV status and screening history. Study sampling was based on sexual identity 
rather than behavior, and thus may not be representative of all MSM. Furthermore, as most 
men lived in urban areas, had health insurance, and were non-Hispanic White, the 
generalizability of our findings to other MSM remains to be established. Currently, no self-
administered anal cancer screening test is licensed for home use outside of research settings. 
Our findings for willingness may overestimate men’s actual use should such a test become 
available. Future studies should therefore examine use if a self-administered home test 
becomes available. We did not establish whether the participants had access to a provider in 
their vicinity who offered anal Pap testing or whether it is currently possible to receive a free 
provider-based test. Both of these factors might reasonably influence men’s willingness to 
undergo such testing relative to a self-collected test. Furthermore, our surveys did not 
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specify whether the home tests were self-collected anal Pap tests, HPV tests, or a 
combination of the two. If men perceive HPV testing to be more accurate, this might affect 
their willingness to undergo screening.
Conclusions
In conclusion, the majority of gay and bisexual men were willing to self-administer an anal 
cancer screening test at home. If anal Pap tests are shown to be an effective means of 
reducing incidence and mortality from invasive anal cancer, allowing men the option of 
home testing could improve screening uptake. This study identified three potentially 
modifiable factors associated with willingness to use a self-test and potential concerns men 
have with using a self-test that could be targeted in future public health campaigns to 
increase screening rates.
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Figure 1. Men’s willingness to screen for anal cancer by self-collected home test and physician-
collected anal Pap test
Error bars show 95% confidence intervals. Data on physician-collected anal Pap testing 
were not available for Study 2.
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Figure 2. Study II Concerns About Self-Administering an Anal Cancer Screening Test at Home
Error bars show 95% confidence intervals.
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Table 1
Participant Characteristics
Study I (n=306) No. (%) Study II (n=428) No. (%)
Sexual orientation
 Gay 236 (77) 309 (72)
 Bisexual 70 (23) 119 (28)
Race/ethnicity
 Non-Hispanic White 247 (81) 273 (64)
 Non-Hispanic Black 14 (5) 28 (7)
 Hispanic 29 (9) 79 (18)
 Other 16 (5) 48 (11)
Age, mean (range, median) 46 (20–59,47) 23 (18–26, 23)
Annual household income
 ≥$50,000 204 (67) 151 (35)
 <$50,000 102 (33) 231 (54)
 Prefer not to answer -- 46 (11)
Education
 Less than college degree 136 (44) 228 (53)
 College degree or higher 170 (56) 200 (47)
Health insurance
 No 44 (14) 86 (20)
 Yes 262 (86) 342 (80)
Reside in urban area
 No 20 (7) 67 (16)
 Yes 286 (93) 361 (84)
Relationship status
 Unmarried or not living with partner 160 (52) 357 (83)
 Married or living with partner 146 (48) 71 (17)
HIV status
 Negative 255 (83) 410 (96)
 Positive 51 (17) 18 (4)
Number of lifetime sexual partners
 0 – 4 35 (11) 202 (47)
 5 or more 271 (89) 226 (53)
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Table 3
Study II Correlates of Willingness to Self-Administer an Anal Cancer Screening Test
No. Willing/Total No. (%) Bivariate OR (95% CI) Adjusted OR (95% CI)
HPV, Anal Cancer, and Screening
Worry about diseases caused by HPV A 1.36 (1.06–1.74)* 1.03 (0.78–1.35)
Perceived severity of disease caused by HPV B 1.09 (0.82–1.45) --
Perceived likelihood of anal cancer C 1.69 (1.22–2.33)** 1.57 (1.12–2.20)*
Awareness of HPV D
 Unaware 33/59 (56) 1.00 1.00
 Aware, low knowledge 138/221 (62) 1.31 (0.73–2.34) 1.09 (0.59–1.99)
 Aware, high knowledge 114/148 (77) 2.64 (1.39–5.01)* 1.94 (0.98–3.85)
Vaccinated for HPV
 No 245/372 (66) 1.00 --
 Yes 40/56 (71) 1.30 (0.70–2.40)
Sexual History
Disclosed sexual orientation to PCP
 Yes 98/136 (72) 1.00 --
 Somewhat 17/27 (63) 0.66 (0.28–1.57)
 No 170/265 (64) 0.69 (0.44–1.09)
Age at first sexual intercourse (oral, anal, or vaginal)
 <16 68/102 (67) 1.00 --
 ≥16 217/326 (67) 0.99 (0.62–1.60)
Number of lifetime sexual partners
 0 – 4 120/202 (59) 1.00 1.00
 5 or more 165/226 (73) 1.85 (1.23–2.77)* 1.42 (0.90–2.23)
History of genital warts
 No 268/408 (66) 1.00 --
 Yes 17/20 (85) 2.96 (0.85–10.27)
HIV status
 Negative 272/410 (66) 1.00 --
 Positive 13/18 (72) 1.32 (0.46–3.78)
History of sexually transmitted disease other than HIV
 No 256/386 (66) 1.00 --
 Yes 29/42 (69) 1.13 (0.57–2.25)
History of HPV infection
 No 267/406 (66) 1.00 --
 Yes 18/22 (82) 2.34 (0.78–7.06)
Demographic Characteristics
Sexual orientation
 Gay 217/309 (70) 1.00 1.00
 Bisexual 68/119 (57) 0.57 (0.37–0.88)* 0.69 (0.43–1.10)
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No. Willing/Total No. (%) Bivariate OR (95% CI) Adjusted OR (95% CI)
Health insurance
 No 53/86 (62) 1.00 --
 Yes 232/342 (68) 1.31 (0.80–2.14)
Race/ethnicity
 Non-Hispanic White 182/273 (67) 1.00 --
 Non-Hispanic Black 20/28 (71) 1.25 (0.53–2.95)
 Hispanic 47/79 (59) 0.73 (0.44–1.23)
 Other 36/48 (75) 1.50 (0.74–3.02)
Age, mean yrs (S.D.) 23.07 (2.40) 1.11 (1.02–1.20)* 1.04 (0.94–1.15)
Annual income
 <$50,000 151/231 (65) 1.00 --
 ≥$50,000 107/151 (71) 1.29 (0.83–2.01)
 Not reported 27/46 (59) 0.75 (0.39–1.44)
Education
 No college degree 139/228 (61) 1.00 1.00
 College degree 146/200 (73) 1.73 (1.15–2.61)* 1.36 (0.83–2.24)
Reside in urban area
 No 45/67 (67) 1.00 --
 Yes 240/361 (66) 0.97 (0.56–1.69)
Relationship status
 Unmarried or not living with partner 231/357 (65) 1.00 --





HPV = human papillomavirus PCP = primary care provider
A
4-point scale, from not at all (coded as 1) to quite a lot (coded as 4)
B
4-point scale, from not at all (coded as 1) to very (coded as 4)
C
4-point scale, from no chance (coded as 1) to high chance (coded as 4)
D
Cutoff for high-knowledge was ≥4/5 HPV knowledge items correct, based on median # correct for entire study
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